Please login to the form below
Professor Andy Black joins Lucid Group as non-executive Chairman
Professor Andy Black, an experienced board-level executive for the life sciences industry, has joined Lucid Group as non-executive Chairman of the Board.
Professor Black, co-founder of Kinapse − an international consultancy to the life sciences industry and the winner of six Fast Track awards − is a Professor of Practice at King’s College London, where he teaches entrepreneurship and supports both the university and King’s Health Partners with commercial partnerships.
Professor Black’s extensive pharmaceutical and management experience will help inform Lucid Group’s growth and development strategy, advancing the group towards its vision of bringing together industry-leading capabilities to tackle some of the most challenging healthcare problems through an outcomes-led approach.
Dennis O’Brien, Co-founder and CEO, Lucid Group, commented: “We are delighted to welcome Andy to the Lucid Group as Chairman. His deep industry knowledge, people focus and experience building a strategic consultancy business, make him invaluable in supporting our global development and growth. He is deeply passionate about making a difference to people’s lives which is directly aligned to the Lucid vision.”
Andy Black, Chairman of the Board, Lucid Group, commented: “I am delighted to be taking on the position of Chairman of the Board at Lucid Group. We share the same values and passion for attracting, developing, and retaining the best people to fuel a purpose-driven organisation. I look forward to working closely with our great team as it continues to build the world’s best healthcare solutions business and transform patients’ lives around the world.”
For further information about Lucid Group please visit www.wearelucidgroup.com or contact Laura Gaskell via email: laura.gaskell@wearelucidgroup.com or call +44 7557 739 059.
About Lucid Group
Founded in 2007, Lucid Group is a global multi-capability healthcare communications consultancy with core expertise in medical strategy, healthcare communications, creative and brand strategy, motion, digital and technology, behaviour change, metrics, and data analytics. We partner with the pharma and biotech industry, delivering life transforming value with connected capabilities to create pioneering solutions that change behaviour, improve clinical practice and advance health outcomes. Transforming lives. Always.
Company Details
Lucid Group Communications Limited
Address:
First Floor, Jubilee House
Third Avenue
Globe Park
Marlow
Bucks
SL7 1EY
UK
Latest content on this profile
- My Lucid journey from PMW to Head of Medical
- Working in Medical Communications has never been about the nine to five. Fusing science and language in the service of both clients and patients, this is typically a fast paced and demanding industry, but one which offers enviable flexibility, variety and intellectual challenge. Leading agency Lucid Group prides itself on the many growth and development opportunities it offers its people. In this article, Katherine Duxbury, Lucid’s Head of Medical, reflects upon her own bespoke working journey over the past 12 years and explains how creativity, collaboration and a passion for science have led to a rewarding, stimulating and self-curated career.
Lucid Group Communications Limited
- Listen, learn and lift off
Lucid Group Communications Limited
- Launch excellence
Lucid Group Communications Limited
- Meet The Lucid Group Talent Team
- Meet our talent team, they're here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your career to the next level with us, you can be assured that you'll have a whole group of people here cheering you on.So, if you’re feeling stuck or unfulfilled in your current role and looking for a company that will provide the personal and career development you need, please check out our open roles here: https://bit.ly/3jhlhUNOr contact one of our talent acquisition managers for a chat:Ellen Field Assoc CIPDElaine DowneyJon TurnerDaniel Newbury
Lucid Group Communications Limited
- Extraordinary lives: advancing change in rare diseases (Part 2)
Lucid Group Communications Limited
- Extraordinary lives: advancing change in rare diseases (Part 2)
- In support of Rare Disease Day, we're excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so important?Because 300 million people worldwide are living with a rare disease. This means that, collectively, the number of people living with a rare disease is equivalent to the population of the world's third-largest country (USA).While we have come a long way since the inception of Rare Disease Day, there's still plenty of work to do.Part 2 of this series focuses on important topics including the role of technology and the opportunities it presents for the rare disease community. The panel also hold captivating insights on how the pandemic has impacted the use of related digital technologies, the role of gene therapy, the major challenges and successes for pharma companies in supporting the rare disease community over the last 13 years, and much, much more.If you’d like to know more about the work we do in rare diseases or would like advice on any healthcare communication challenges please get in touch with Clare Reynolds on LinkedIn or by email: clare.reynolds@wearelucidgroup.comAbout Lucid GroupFounded in 2007, Lucid Group is a global multi-capability healthcare consultancy with core expertise in medical strategy, healthcare communications, creative and brand strategy, motion, digital and technology, behaviour change, metrics, and data analytics. We partner with the pharma and biotech industry, delivering life-transforming value with connected capabilities to create pioneering solutions that change behaviour, improve clinical practice and advance health outcomes. Transforming lives. Always.
Lucid Group Communications Limited
